MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    LRRK2 and GBA Founder Mutations and their Interactions in Parkinson’s Disease

    M. Kmiecik, G. Riboldi, R. Schneider, K. Stagaman, T. Filshtein Sonmez, A. Guan, M. Wetzel, P. Fontanillas, M. Holmes, S. Aslibekyan, L. Norcliffe-Kaufmann (Sunnyvale, USA)

    Objective: To evaluate the symptoms of Parkinson’s disease (PD) and time to diagnosis in single and dual carriers of LRRK2 G2019S and GBA N370S. Background:…
  • 2024 International Congress

    Association of Gaucher-related and Parkinson’s-private GBA1 variants with progression of PD: A longitudinal mixed model analysis.

    A-M. Hanff, C. Mccrum, A. Rauschenberger, S. Pachchek, G. Aguayo, C. Pauly, S. Jónsdóttir, O. Tsurkalenko, L. Pauly, Z. Landoulsi, A. Leist, P. May, M. Zeegers, R. Krüger (Strassen, Luxembourg)

    Objective: To compare progression of motor- and non-motor symptoms in people with Parkinson’s disease (PD) with Gaucher-related gene glucocerebrosidase (GBA1) variants compared to people with…
  • 2024 International Congress

    MDSGene Update and Expansion: Clinical and Genetic Spectrum of LRRK2 Variants in Parkinson´s Disease

    C. Krüger, S-Y. Lim, A. Buhrmann, FL. Fahrig, C. Gabbert, N. Bahr, H. Madoev, C. Marras, C. Klein, K. Lohmann (Luebeck, Germany)

    Objective: To provide a comprehensive and systematic overview of published data on carriers of pathogenic variants in the LRRK2 gene, including demographic, clinical, and genetic…
  • 2024 International Congress

    Predictive Value of Brain Structural Changes on Motor Outcomes Following VIM Thalamotomy in Essential Tremor: Preliminary Results

    Y. Samanci, A. Bayram, H. Gezegen, AH. Duzkalir, E. Sahin, B. Samanci, S. Peker (Istanbul, Turkey)

    Objective: To identify structural MRI factors that correlate with variations in motor outcomes for essential tremor (ET) patients after Gamma Knife thalamotomy (GKT). Background: Stereotactic…
  • 2024 International Congress

    The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach

    AT. Cimmino, P. Sanginario, F. Musso, D. Genovese, A. de Biase, M. Petracca, F. Bove, C. Piano, FD. Tiziano, AR. Bentivoglio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

    Objective: Our study aimed to identify the genetic determinants and their prevalence in an Italian cohort of Parkinson’s disease (PD) patients. Background: Advances in genetics…
  • 2024 International Congress

    Implications of BSCL2 Mutation in the Pathogenesis of Parkinson’s Disease

    AY. Regalado-Mustafá, CF. álvarez-Hernandez, WF. Moguel-Cardin, AL. Guerra-Anzaldo, A. Domínguez-García, MAG. Medrano-Delgado, AJ. Hernández-Medrano, A. Cervantes-Arriaga, A. Abundes-Corona, A. Guevara-Salinas, M. Rodríguez-Violante, N. Monroy-Jaramillo, LV. Adalid-Peralta (Mexico City, Mexico)

    Objective: To report a case of a probable association between a mutation in the BSCL2 gene (Berardinelli-Seip Congenital Lipodystrophy 2) and Parkinson's disease (PD). Background:…
  • 2024 International Congress

    Utility of using long-read whole genome sequencing to solve exome negative early-onset and familial Parkinson’s disease: a series of 106 individuals

    G. Cogan, K. Bilingsley, K. Daida, C. Tesson, T. Courtin, M. Ferrien, A. Singleton, S. Lesage, C. Blauwendraat, A. Brice (Paris, France)

    Objective: (i) To identify complex variants usually not visible by short-read whole exome sequencing in known genes of Parkinson’s disease (PD) such as structural variants…
  • 2024 International Congress

    Transcriptome analysis of proteasome and inflammation in the substantia nigra of Parkinson’s disease patients: the GEO database.

    TL. Ho, HD. Nguyen, EJ. Ko, YE. Kim (Jeju-si, Republic of Korea)

    Objective: In this study, we analyzed transcriptome data regarding protein degradation pathways and inflammation sourced from GEO database. Background: Parkinson's disease (PD) is the second…
  • 2024 International Congress

    Deep brain stimulation of bilateral ventral intermediate nucleus in patients with neuronal intranuclear inclusion disease

    YM. Sun, LQ. Lang, J. Hu, JJ. Wu (Shanghai, China)

    Objective: To evaluate the effect and the side effects of deep brain stimulation on the tremor of a patient with neuronal intranuclear inclusion disease (NIID).…
  • 2024 International Congress

    Strategic Training Framework for Advancing Research Capacity through GP2

    MT. Perinan, S. Dey, H. Leonard, M. Makarious, A. Martinez-Carrasco, A. Zirra, P. Reyes-Perez, P. Saffie Awad, A. Sanyaolu, P-J. Kung, Y-W. Tay, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Seville, Spain)

    Objective: To promote and facilitate learning by providing resources and expertise to address the training needs of the Global Parkinson’s Genetics Program (GP2; www.gp2.org) and…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley